Terje Enebakk
Bodo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Comparison of cytokine changes in three different lipoprotein apheresis systems in an ex vivo whole blood model.
Journal: Journal of clinical apheresis
Published: June 23, 2019
Telemonitoring and Quality of Life in Patients after 12 Months Following a Pacemaker Implant: the Nordland Study, a Randomised Trial.
Journal: International journal of environmental research and public health
Published: April 23, 2019
Addition of marine omega-3 fatty acids to statins in familial hypercholesterolemia does not affect in vivo or in vitro endothelial function.
Journal: Journal of clinical lipidology
Published: February 26, 2019
Health-related quality of life on tele-monitoring for users with pacemakers 6 months after implant: the NORDLAND study, a randomized trial.
Journal: BMC geriatrics
Published: April 29, 2018
Granulocyte and monocyte CD11b expression during plasma separation is dependent on complement factor 5 (C5) - an ex vivo study with blood from a C5-deficient individual.
Journal: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
Published: June 23, 2017
LDL apheresis activates the complement system and the cytokine network, whereas PCSK9 inhibition with evolocumab induces no inflammatory response.
Journal: Journal of clinical lipidology
Published: July 16, 2016
Transition from LDL apheresis to evolocumab in heterozygous FH is equally effective in lowering LDL, without lowering HDL cholesterol.
Journal: Atherosclerosis
Published: April 06, 2016
Complement profile and activation mechanisms by different LDL apheresis systems.
Journal: Acta biomaterialia
Published: October 24, 2011
Showing 1-8 of 8
Last Updated: 09/26/2026